Type

Issue

Tag

GLOBE OP-ED: Lown president reacts to killing of United Health CEO

The killing of United Health CEO Brian Thompson triggered an uproar from the many Americans frustrated with the failures of our health care system. In a recent op-ed in the Boston Globe, Lown president Dr. Vikas Saini shares his take on this important moment and the changes we need to build a radically better health […] More

Five ways to reduce back surgery overuse

The Lown Institute released new data on unnecessary back surgeries in Medicare, identifying 200,000 low-value procedures and $2 billion in Medicare dollars wasted over three years. Back surgery overuse varies widely among states, hospitals, and even doctors in the same hospital. We brought together Dr. Sohail Mirza, orthopedic surgeon and professor at Dartmouth College, and […] More

Black mothers more likely to get unnecessary C-sections, study says

Are Black mothers more likely to have unscheduled C-sections? A new working paper from the National Bureau of Economic Research suggests yes–and that their likelihood of an unscheduled C-section was greater when there were operating rooms going unused.  Same hospital, different c-section rates While C-sections can be a lifesaving option when necessary, they are invasive […] More

Can AI help reduce medical debt? It depends on how hospitals use it…

Could AI and other machine learning help ameliorate our nation’s medical debt crisis—or will it make the problem worse? It all depends on how hospitals use these tools, write Kelsey Chalmers, PhD, our own Director of Research, Data Science at the Lown Institute, and Christopher W. Goodman, MD, Clinical Assistant Professor of Internal Medicine at the University of South Carolina School of Medicine, in a recent JAMA Internal Medicine viewpoint. More

Should patients care about 340B? 

340B is more than a big pile of money. The program is a band-aid covering up huge problems with our health system that can no longer be ignored. The 340B drug discount program is a hugely important policy issue for hospitals and drug companies, but the most of the rest of us have never heard of it or barely understand it. Why is pharma and the hospital industry getting so worked up about 340B, and how does any of this matter? Here’s what you need to know about a growing policy battle… More